Survey shows patient safety is improved by reducing variability in ultrasound-guided PIV insertions

Survey shows patient safety is improved by reducing variability in ultrasound-guided PIV insertions

Press releases may be edited for formatting or style | September 25, 2019 Cardiology Ultrasound
HARTWELL, Ga., Sept. 25, 2019 /PRNewswire/ -- A sterile barrier dressing can improve patient safety while lowering costs up to 67 percent, when used as part of a standardized process for placing ultrasound-guided peripheral IV (UGPIV) catheters, according to a new study from PICC Excellence and Sharp HealthCare (San Diego). The results will be presented as a poster at the upcoming meeting of the Association for Vascular Access (AVA).

A multi-center prospective survey was designed to evaluate the barrier and securement dressing (UltraDrapeTM, Parker Laboratories) and establish a consistent, cost-effective UGPIV procedure across three hospitals within the Sharp system. Prior to the study, an analysis showed a high level of variability in UGPIV practices among the hospitals. This variability included inconsistent use of probe covers, transparent dressings and ultrasound gel (both sterile and non-sterile).

"We can minimize contamination during PIV insertions through proper aseptic technique, but its effectiveness is diminished if it's not done consistently," said study co-author and PICC Excellence CEO Nancy Moureau, RN, PhD, CRNI, CPUI, VA-BC. "By separating the ultrasound probe and gel from the skin, the sterile barrier dressing standardizes the procedure in a way that promotes a better aseptic non-touch insertion technique."

Servicing GE/Siemens Nuclear Medicine equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.

This standardization is the key to making UGPIV procedures safer, faster and more cost effective, she said. Dr. Moureau is an internationally recognized expert and consultant in vascular access.

Of the Sharp clinicians surveyed after 210 UGPIV insertions, 99 percent recommended adoption of the new standardized procedure and use of the barrier dressing. Respondents also expressed a strong preference for the dressing over traditional sterile probe covers. Overall, there were high levels of agreement that the dressing provided a sufficient barrier against site contamination, and improved patient care by facilitating better aseptic technique.

"The innovative design of the sterile barrier dressing helps us perform cleaner insertions by keeping the gel separate from the probe and the insertion site," said a clinician involved in the study. "Since the evaluation, we've continued to use UltraDrape for many of our ultrasound-guided PIV insertions because it provides excellent aseptic protection for our patients while being easier to use than a regular probe cover."

In addition, the study showed a significant cost savings with the sterile barrier dressing. An economic analysis found that by eliminating the need for additional securement dressings, sterile gels and probe covers, the dressing reduced the cost of a UGPIV insertion by 55 percent compared to the system's previous procedure and 67 percent compared to use of a full sterile UGPIV kit.

You Must Be Logged In To Post A Comment